BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

6:13 PM
 | 
May 08, 2008
 |  BC Extra  |  Clinical News

Fortigel meets hypogonadism endpoint

ProStrakan (LSE:PSK) said Fortigel testosterone met the primary endpoint of at least 75% of patients achieving a plasma testosterone reference range of 300-1140 ng/dL at day...

Read the full 117 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >